Literature DB >> 11470700

Predictors of nonrecovery in acute traumatic sixth nerve palsy and paresis.

J M Holmes1, R W Beck, K E Kip, P J Droste, D A Leske.   

Abstract

PURPOSE: To evaluate whether nonrecovery from acute traumatic sixth nerve palsy could be predicted from demographic factors or palsy characteristics.
DESIGN: Prospective, observational case series
SETTING: Multicenter (academic and private practices). OUTCOME MEASURE: Nonrecovery, defined as the presence of diplopia in primary position or more than 10 prism diopters of distance esotropia in primary position at 6 months after onset.
METHODS: Using data from a previously described cohort of 84 eligible patients with acute traumatic sixth nerve palsy, we performed multivariate analyses of demographic factors and palsy characteristics.
RESULTS: Nonrecovery at 6 months after onset was associated with a complete palsy (adjusted risk ratio, 9.11; 95% confidence interval [CI], 2.77-14.84) and with a bilateral palsy or paresis (adjusted risk ratio, 2.53; 95% CI, 0.98-4.29). The choice of conservative management (observation, prism, or patch) versus acute injection of Botulinum toxin (within 3 months of injury) did not influence final recovery.
CONCLUSIONS: In acute traumatic sixth nerve palsy or paresis, failure to recover by 6 months after onset was associated independently with inability to abduct past midline at presentation and bilaterality. Although the overall recovery rate is high in acute traumatic sixth nerve palsy or paresis, a complete or bilateral case has a poor prognosis and is more likely to need strabismus surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470700     DOI: 10.1016/s0161-6420(01)00633-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  Neuro-ophthalmic deficits after head trauma.

Authors:  Sarah M Jacobs; Gregory P Van Stavern
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

2.  Predictors of Good Motor and Sensory Outcomes Following Strabismus Surgery for Patients with Third Nerve Palsies.

Authors:  Jason H Peragallo; Beau B Bruce; Amy K Hutchinson; Phoebe D Lenhart; Valérie Biousse; Nancy J Newman; Scott R Lambert
Journal:  Neuroophthalmology       Date:  2014-10-09

3.  Functional and Motor Outcomes of Strabismus Surgery for Chronic Isolated Adult Sixth Nerve Palsy.

Authors:  Jason H Peragallo; Beau B Bruce; Amy K Hutchinson; Phoebe D Lenhart; Valérie Biousse; Nancy J Newman; Scott R Lambert
Journal:  Neuroophthalmology       Date:  2014-10-09

4.  Isolated abducens nerve palsy after closed head injury in a child.

Authors:  Ioannis Asproudis; Eleni Vourda; Paraskevas Zafeiropoulos; Andreas Katsanos; Meropi Tzoufi
Journal:  Oman J Ophthalmol       Date:  2015 Sep-Dec

5.  Post-traumatic Unilateral Avulsion of the Abducens Nerve with Damage to Cranial Nerves VII and VIII: Case Report.

Authors:  Fumiyuki Yamasaki; Yuji Akiyama; Ryu Tsumura; Manish Kolakshyapati; Rupendra Bahadur Adhikari; Takeshi Takayasu; Ryo Nosaka; Kaoru Kurisu
Journal:  NMC Case Rep J       Date:  2016-05-16

6.  Acute Abducens Nerve Palsy in a Patient who Sustained Mechanical Trauma to the Orbit.

Authors:  Adam Geressu; Jayaprakash Patil; Jessica Cody
Journal:  Br Ir Orthopt J       Date:  2021-12-09

Review 7.  A Review of Transposition Techniques for Treatment of Complete Abducens Nerve Palsy.

Authors:  Mohammad Reza Akbari; Babak Masoomian; Arash Mirmohammadsadeghi; Motahhareh Sadeghi
Journal:  J Curr Ophthalmol       Date:  2021-10-22

8.  Concomitant abducens and facial nerve palsies following bone temporal fracture: Case report.

Authors:  Achraf Amine Sbai; FatimZahra Es-Sahli; Azeddine Lachgar; Fahd Elayoubi
Journal:  Ann Med Surg (Lond)       Date:  2022-08-04

9.  Supramaximal Horizontal Rectus Recession-Resection Surgery for Complete Unilateral Abducens Nerve Palsy.

Authors:  Zhonghao Wang; Licheng Fu; Tao Shen; Xuan Qiu; Xinping Yu; Huangxuan Shen; Jianhua Yan
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.